Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02676349
Brief Title: Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44)

First Submitted : February 3, 2016
First Submitted that Met QC Criteria : February 3, 2016
First Posted : February 8, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : August 11, 2020
Last Update Posted : August 12, 2020